• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Vor Biopharma Inc. - Common Stock (NQ:VOR)

    15.07 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EDT, May 14, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 3,652
    Open 15.07
    Bid (Size) 14.83 (200)
    Ask (Size) 15.09 (100)
    Prev. Close 15.07
    Today's Range 15.07 - 15.07
    52wk Range 3.064 - 65.80
    Shares Outstanding 66,956,800
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Vor Bio Announces Publication of Interim Analysis of TELIGAN, a China Phase 3 Trial of Telitacicept in IgA Nephropathy, in The New England Journal of Medicine
    From Vor Biopharma
    Via GlobeNewswire
    News headline image
    Vor Bio Reports First Quarter 2026 Financial Results and Provides Corporate Update
    From Vor Biopharma
    Via GlobeNewswire

    Performance

    YTD
    +29.5%
    +29.5%
    1 Month
    -5.0%
    -5.0%
    3 Month
    +15.3%
    +15.3%
    6 Month
    +54.6%
    +54.6%
    1 Year
    +340.6%
    +340.6%

    More News

    Read More
    News headline image
    Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
    From Vor Biopharma
    Via GlobeNewswire
    News headline image
    Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
    From Vor Biopharma
    Via GlobeNewswire
    VOR Shares Rally Over 40%In Pre-Market Trade After JPMorgan Initiates Bullish Coverage ↗
    Via Stocktwits
    News headline image
    Vor Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
    From Vor Biopharma
    Via GlobeNewswire
    News headline image
    Vor Bio Doses First Patient in Global Phase 3 UPSTREAM SjD Registrational Trial of Telitacicept in Primary Sjögren’s Disease
    From Vor Biopharma
    Via GlobeNewswire
    News headline image
    What's Behind The Jump In Vor Biopharma Stock? ↗
    Via Benzinga
    News headline image
    Vor Bio Announces $75 Million Private Placement with TCGX
    From Vor Biopharma
    Via GlobeNewswire
    News headline image
    Vor Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Vor Biopharma
    Via GlobeNewswire
    News headline image
    Vor Bio to Participate in the 46th Annual TD Cowen Health Care Conference
    From Vor Biopharma
    Via GlobeNewswire
    News headline image
    Vor Bio to Participate in the 44th Annual J.P. Morgan Healthcare Conference
    From Vor Biopharma
    Via GlobeNewswire
    News headline image
    Vor Bio Appoints RA Capital’s Andrew Levin, M.D., Ph.D., and Forbion’s Wouter Joustra to Board of Directors
    From Vor Biopharma
    Via GlobeNewswire
    News headline image
    Vor Bio Announces $150 Million Private Placement
    From Vor Biopharma
    Via GlobeNewswire
    News headline image
    What's going on in today's session ↗
    Via Chartmill
    News headline image
    What's going on in today's pre-market session ↗
    Via Chartmill
    News headline image
    Futures Tread Cautiously Pre-Market As Investors Await Key Fed Decision: NVDA, XCUR, GME, CASY Among Stocks To Watch ↗
    Via Stocktwits
    Topics ETFs Economy Government
    News headline image
    Vor Bio Reports Third Quarter 2025 Financial Results and Provides Corporate Update
    From Vor Biopharma
    Via GlobeNewswire
    News headline image
    Top movers analysis one hour before the close of the markets on 2025-11-11: top gainers and losers in today's session. ↗
    Via Chartmill
    News headline image
    Let's take a look at the stocks that are in motion in today's session. ↗
    Via Chartmill
    News headline image
    Dow Gains More Than 300 Points; Energy Vault Holdings Shares Jump ↗
    Via Benzinga
    Topics Stocks
    News headline image
    12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
    Via Benzinga
    News headline image
    Let's uncover which stocks are experiencing notable gaps during today's session. ↗
    Via Chartmill
    News headline image
    Vor Biopharma Secures $100 Million Offering After Reporting Efficacy In Kidney Disease Trial ↗
    Via Benzinga
    News headline image
    US Stocks Mixed; Sea Shares Gain After Q3 Results ↗
    Via Benzinga

    Frequently Asked Questions

    Is Vor Biopharma Inc. - Common Stock publicly traded?
    Yes, Vor Biopharma Inc. - Common Stock is publicly traded.
    What exchange does Vor Biopharma Inc. - Common Stock trade on?
    Vor Biopharma Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Vor Biopharma Inc. - Common Stock?
    The ticker symbol for Vor Biopharma Inc. - Common Stock is VOR on the Nasdaq Stock Market
    What is the current price of Vor Biopharma Inc. - Common Stock?
    The current price of Vor Biopharma Inc. - Common Stock is 15.07
    When was Vor Biopharma Inc. - Common Stock last traded?
    The last trade of Vor Biopharma Inc. - Common Stock was at 05/14/26 04:00 PM ET
    What is the market capitalization of Vor Biopharma Inc. - Common Stock?
    The market capitalization of Vor Biopharma Inc. - Common Stock is 1.01B
    How many shares of Vor Biopharma Inc. - Common Stock are outstanding?
    Vor Biopharma Inc. - Common Stock has 1B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.